Wednesday

8th Feb 2023

EU stands by anti-Covid drug, despite WHO doubts

  • The WHO found 'a lack of evidence that remdesivir improved outcomes that matter to patients' - but it has already been distributed by the EU (Photo: Jernej Furman)

The European Commission has not written off remdesivir to treat Covid-19, after the drug was distributed to tens of thousands of people - despite a recent statement from the World Health Organization (WHO) that the antiviral medicine is ineffective and should not be used.

"I will not get into a scientific analysis of remdesivir, this is for science to do that," said European Commission president Ursula von der Leyen on Friday (20 November), when pressed on the issue.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

She noted contracts signed with pharmaceutical companies for vaccines have built-in liability clauses. "They have to be effective and safe," she said.

But the commission had already paid the US-based biopharmaceutical company Gilead some €70m to treat 33,380 people with remdesivir.

Those doses were distributed across the EU and the UK, between August and October.

"The medication has been disbursed in several instalments," said the European Commission in early October.

The commission then signed a €1bn joint-procurement contract with Gilead for 500,000 courses of the drug.

The antiviral, also known by the brand name Veklury, was given the green light by the European Medicines Agency.

Veklury contains the active substance remdesivir.

The agency said Veklury had cut recovery times for Covid patients with pneumonia requiring supplemental oxygen.

But guidelines issued by a panel at the WHO on Friday (20 November) now appear to contest those findings.

"The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients," it said.

"Especially given the costs and resource implications associated with remdesivir ... the panel felt the responsibility should be on demonstrating evidence of efficacy, which is not established by the currently available data," it added.

For its part, Gilead contested the findings by the panel.

EU commission keeps vaccine price secret

The European Commission is about to sign a fourth contract for hundreds of millions of vaccine doses against Covid-19. The contracts include non-disclosure clauses, meaning things like price or even where they will be produced remains confidential.

EU secures remdesivir supplies for 30,000 patients

The European Commission signed this week a €63m contract with the US-based biopharmaceutical company Gilead to secure batches of remdesivir for 30,000 patients with "severe" Covid-19 symptoms - after the US left Europe and most of the world without supplies.

EU seals new Covid-19 deal amid global distribution fears

The European Commission sealed a second Covid-19 vaccine deal, amid fears over the fair distribution of supplies worldwide. So far Brussels has secured, or is negotiating, a stock of nearly two billion doses.

Feature

Eleven suicides daily — Spain's not-so-silent pandemic

With the emergence of the pandemic, Spain's suicide figures have worsened, bringing to the surface the long waiting times, the lack of health personnel, and the absence of a national suicide prevention plan.

Analysis

MEPs push for greater powers for workers' councils

European Works Councils can play a key role for workers and their unions to bargain effectively — but what are they, why have they been neutered, and why is big business objecting to greater powers?

Analysis

MEPs push for greater powers for workers' councils

European Works Councils can play a key role for workers and their unions to bargain effectively — but what are they, why have they been neutered, and why is big business objecting to greater powers?

Latest News

  1. Eight EU states press for more Turkey-style migrant swap deals
  2. EU buries head deeper in sand over Israel's apartheid
  3. Polish MEP also went on freelance Azerbaijan trip
  4. Why Europe's interminable compromises are a virtue
  5. Wales' message to Europe: 'We'll be back'
  6. MEPs to vote on risky 'hydrogen for home heating' rule
  7. The man who won't stop filing info requests until every EU doc is public
  8. EU hands Libya coast guard boats ahead of migration summit

Stakeholders' Highlights

  1. EFBWWEU Social Dialogue review – publication of the European Commission package and joint statement of ETUFs
  2. Oxfam InternationalPan Africa Program Progress Report 2022 - Post Covid and Beyond
  3. WWFWWF Living Planet Report
  4. EFBWWEFBWW Executive Committee report on major abuses, labour crime and subcontracting
  5. European Parliamentary Forum for Sexual & Reproductive Rights (EPF)Launch of the EPF Contraception Policy Atlas Europe 2023. 8th February. Register now.
  6. Europan Patent OfficeHydrogen patents for a clean energy future: A global trend analysis of innovation along hydrogen value chains

Join EUobserver

Support quality EU news

Join us